UM Ventures News
Three Recent UM Baltimore Start-Ups Enter Commercial Phase
Tuesday, October 15, 2013
UMB Licensee Countervail Wins $343,000 Grant to Support Drug Research
Monday, October 14, 2013
Why Brain Surgeons Want Help From A Maggot-Like Robot
Saturday, October 5, 2013
Gliknik Enters Into Licensing Agreement With Pfizer For Drug Candidate Targeting Autoimmune Diseases
Monday, September 30, 2013
MedImmune, UMB ink $6 million research partnership
Wednesday, September 25, 2013
Profectus BioSciences Presents Data at Filovirus Medical Countermeasures Meeting
Monday, September 23, 2013
Redox Power Systems betting the future of electricity lies in fuel cells
Monday, August 19, 2013
UMB's Licensing Deals Fuel Local Life Sciences Community
Tuesday, August 6, 2013
Rexahn Pharmaceuticals In-Licenses Breakthrough Oncology Drug Delivery Platform
Wednesday, July 17, 2013